ARCHIVES

More Clinical Trials Money Top Priority, DeVita Says; Drug Discovery Groups RFA Gets 12 Applications

This article is from The Cancer Letter archive.

Vol. 10 No. 08 | February 24, 1984

Download PDF Visit The Full Archive

Related Articles

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

Group Chairs Respond to Center Directors’ White Paper

April 1, 2011

Chabner Object To Yarbro’s Remarks On Federal Role In Clinical Research

April 15, 1983

ASCO Proposes Principles For Future Debate on Medicaid

November 21, 2014

ASCO, Pathologists Publish Guideline On Improving Accuracy Of HER2 Testing

December 29, 2006

In Brief: Cancer Act renewal, Appropriations Bill Caught In Squeeze Between Conventions

August 1, 1980